Ji‐Kai Liu
- Pharmacology top 0.05%
- Fungal Biology and Applications 292
- Microbial Natural Products and Biosynthesis 218
- Pharmacology top 0.1%
- Fungal Biology and Applications 292
- Microbial Natural Products and Biosynthesis 218
- Biotechnology top 0.2%
- Organic Chemistry top 0.5%
- Chemical synthesis and alkaloids 91
-
- Natural product bioactivities and synthesis 72
- Phytochemical compounds biological activities 54
-
- Phytochemistry and Biological Activities 69
-
- Sesquiterpenes and Asteraceae Studies 46
-
- Plant Pathogens and Fungal Diseases 42
- Cited by
- PharmacologyBiotechnology
- Journals
- Chemical Reviews (2 papers)Proceedings of the National Academy of Sciences (1 paper)Journal of Biological Chemistry (1 paper)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Ji‐Kai Liu
620 papers receiving 11.6k citations
Hit Papers
Peers
Comparison fields: 5 of 170
- Pharmacology 4.7k
- Pharmacology 1.3k
- Biotechnology 1.1k
- Complementary and alternative medicine 792
- Organic Chemistry 2.6k
Countries citing papers authored by Ji‐Kai Liu
This map shows the geographic impact of Ji‐Kai Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ji‐Kai Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ji‐Kai Liu more than expected).
Fields of papers citing papers by Ji‐Kai Liu
This network shows the impact of papers produced by Ji‐Kai Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ji‐Kai Liu. The network helps show where Ji‐Kai Liu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ji‐Kai Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 0 | |
| 4 | 2023 | 4 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 13 | |
| 7 | 2023 | 3 | |
| 8 | 2023 | 8 | |
| 9 | 2023 | 8 | |
| 10 | 2022 | 13 | |
| 11 | 2022 | 13 | |
| 12 | 2020 | 44 | |
| 13 | 2019 | 33 | |
| 14 | 2019 | 7 | |
| 15 | 2019 | 186 | |
| 16 | 2019 | 47 | |
| 17 | A new lignan from Elaeagnus lanceolata (Elaeagnaceae). | 2010 | 4 |
| 18 | Fungicidal activity of L-696, 474 and cytochalasin D from the ascomycete Daldinia concentrica against plant pathogenic fungi | 2007 | 2 |
| 19 | 2004 | 62 | |
| 20 | Studies on the Chemical Constituents of Pyrus Communis | 1987 | 1 |
About Ji‐Kai Liu
Ji‐Kai Liu is a scholar working on Pharmacology, Pharmacology and Biotechnology, having authored 637 papers that have together received 11.8k indexed citations. Recurring topics across this work include Fungal Biology and Applications (292 papers), Microbial Natural Products and Biosynthesis (218 papers), Chemical synthesis and alkaloids (91 papers), Natural product bioactivities and synthesis (72 papers), Phytochemistry and Biological Activities (69 papers), Phytochemical compounds biological activities (54 papers), Sesquiterpenes and Asteraceae Studies (46 papers) and Plant Pathogens and Fungal Diseases (42 papers). The work is most often cited by research in Pharmacology (4.7k citations), Pharmacology (1.3k citations) and Biotechnology (1.1k citations). Ji‐Kai Liu has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Tao Feng, Zheng-Hui Li, Ze‐Jun Dong, Fei Wang, He‐Ping Chen, Yongfeng Gao, Juan He, Dongze Liu, Zhen‐Zhu Zhao and Zhong‐Yu Zhou. Their work appears in journals such as Chemical Reviews, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.